Abstract:Introduction Identification of biomarkers associated with the risk of psychosis manifestation in juvenile patients with depression may contribute to a better understanding of the pathogenesis of mental disorders and early diagnosis. Objectives To determine the level of pro-inflammatory and anti-inflammatory cytokines and other inflammatory indicators in the plasma of juvenile patients with depression and clinically high risk of psychosis, and to study the correlation of these markers with the severity of psychopathologic symptoms. Methods 80 young men aged 16-24 years with the first depressive episode (F32.1-2, F32.38, F32.8) were examined. Based on the severity of attenuated psychotic symptoms (APS) in the structure of depression according to the SOPS scale, all patients were divided into two groups - with clinically high risk of psychosis (n=58) and with depression without APS (n=22). The HDRS-21 and SANS scales were also used for psychometric assessment. Serum level of cytokines TNF-α, IL-6, IL-8, IL-10, TNF-α/IL-6 ratio, TNF-α/IL-10 ratio, leukocyte elastase (LE) and α1-proteinase inhibitor (α1-PI) activity, C-reactive protein (CRP) concentration, and the level of autoantibodies to S-100B protein were determined. Results Both groups of patients showed a high level of inflammation assessed by LE and α1-PI activity (p>0.05). Significantly higher level of IL-6 (p=0.03), CRP concentration (p=0.026) and TNF-α/IL-10 ratio (p=0.032) were found in patients with clinically high risk of psychosis. This group was also characterised by high level of autoantibodies to the S-100B protein compared to patients with depression without APS (p=0.048). In the high clinical risk group, correlations were found between the SOPS positive subscale score and the level of TNF-α (R=0.32, p=0.017), IL-8 (R=-0.3, p=0.034), TNF-α/IL-6 ratio (R=0.30, p=0.021) and TNF-α/IL-10 ratio (R=0.32, p=0.014). The SOPS negative subscale score correlated with CRP concentration (R=0.3, p=0.043). The SOPS total score correlated with TNF-α/IL-10 ratio (R=0.31, p=0.021). In this group of patients, the level of IL-10 was found to correlate with the duration of the disease (R=0.48, p<0.001). In patients with depression without APS, the level of IL-6 was correlated with the severity of depression according to the HDRS scale, and the level of TNF-α was associated with the duration of the depressive episode (R=0.51, p=0.029). Conclusions The obtained results confirm the involvement of inflammation in the development of juvenile depression. Qualitative and quantitative characteristics of the spectrum of immune markers and the cytokine profile, and correlations with the severity of psychopathologic symptoms were revealed in patients with clinically high risk of psychosis. Disclosure of Interest None Declared

Thought Disorders in Depressive Adolescents with High-Risk for Schizophrenia

Predictive value of thought disorder in new-onset psychosis

Development and validation of a Disorganised Thoughts Scale: a new measure to assess thinking difficulties in the general population

Association between suicidal ideation, negative symptoms and theory of mind in first episode psychosis

The Association Between Suicide Risk and Affective Temperaments in First-Episode and Neuroleptic-Naïve Major Depressive Disorder

Symptom Dimensions and Cognitive Impairments in Individuals at Clinical High Risk for Psychosis

Cognitive Function in First-Episode Adolescent-Onset Schizophrenia Before and after Treatment

Dysfunctional Resting-State Connectivities of Brain Regions with Structural Deficits in Drug-Naive First-Episode Schizophrenia Adolescents

Cognitive impairment in patients with first-episode schizophrenia and the correlation of different mental symptoms

Prevalence and Clinical Correlates of and Cognitive Function at the Time of Suicide Attempts in First-Episode and Drug-Naive Patients With Schizophrenia.

Decline of Anterior Cingulate Functional Network Efficiency in First-Episode, Medication-Naïve Somatic Symptom Disorder and Its Relationship with Catastrophizing.

Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaire

Features of the spectrum of immune markers in patients with juvenile depression with clinically high risk of psychosis

Factors Associated with Objective and Subjective Cognitive Impairment in Chinese Patients with Acute Major Depressive Disorder

Deconstructing depression: specific symptoms predict future suicide attempts among clinical adolescents

Early-onset schizophrenia: studying the links between cognitive and clinical dimensions

The Relationship Between Depressive Symptoms and Psychological Variables in Patients With Schizophrenia

Dysconnectivity of the Nucleus Accumbens and Amygdala in Youths with Thought Problems: A Dimensional Approach

The cognitive aspect of formal thought disorder and its relationship with global social functioning and the quality of life in schizophrenia

Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis

Cognitive and motor alterations in children attending a psychiatric clinic in relation to schizophrenia spectrum family antecedents and thought problems